Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

<p><strong>Background</strong> There have been no studies of the patterns of post-marketing withdrawals of medicinal products to which adverse reactions have been attributed. We identified medicinal products that were withdrawn because of adverse drug reactions, examined the eviden...

書目詳細資料
Main Authors:	Onakpoya, IJ, Heneghan, CJ, Aronson, JK
格式:	Journal article
語言:	English
出版:	BioMed Central 2016

相似書籍

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
由: Onakpoya, I, et al.
出版: (2016)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
由: Onakpoya, I, et al.
出版: (2016)

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
由: Onakpoya, I, et al.
出版: (2017)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
由: Onakpoya, I, et al.
出版: (2017)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
由: Onakpoya, I
出版: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
由: Onakpoya, I, et al.
出版: (2017)

Pharmacogenetics and adverse drug reactions
由: Ferner, R, et al.
出版: (2010)

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
由: Loke, Y, et al.
出版: (2006)

An agenda for research on adverse drug reactions.
由: Aronson, J
出版: (2007)

Adverse drug reactions--no farewell to harms.
由: Aronson, J
出版: (2007)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
由: Onakpoya, IJ, et al.
出版: (2020)

Adverse drug reactions: definitions, diagnosis, and management.
由: Edwards, I, et al.
出版: (2000)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
由: Aronson, J
出版: (2008)

Adverse drug reactions: keeping up to date.
由: Aronson, J, et al.
出版: (2002)

Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
由: Aronson, J
出版: (2013)

Paradoxical reactions: Under-recognized adverse effects of drugs?
由: Hauben, M, et al.
出版: (2006)

National differences in publishing papers on adverse drug reactions.
由: Ferner, R, et al.
出版: (2005)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
由: Talbot, J, et al.
出版: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
由: Talbot, J, et al.
出版: (2012)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
由: Aronson, J
出版: (2012)

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
由: Smith, C, et al.
出版: (1996)

Health risks of unknown medicines: evidence from adverse drug reactions in Laos
由: Caillet, C, et al.
出版: (2016)

Joining the DoTS: new approach to classifying adverse drug reactions.
由: Aronson, J, et al.
出版: (2003)

Spontaneous reporting to regulatory authorities of suspected adverse drug reactions to COVID-19 vaccines over time: the effect of publicity
由: Ferner, RE, et al.
出版: (2022)

Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.
由: Aronson, J
出版: (2005)

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.
由: McDowell, SE, et al.
出版: (2013)

Pharmacovigilance and reporting adverse drug reactions.
由: Isa NM,
出版: (2014)

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.
由: Aronson, J, et al.
出版: (2010)

Monitoring for the Adverse Effects of Drugs
由: Coleman, J, et al.
出版: (2008)

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
由: Derry, S, et al.
出版: (2001)

Incomplete evidence: The inadequacy of databases in tracing published adverse drug reactions in clinical trials
由: Derry, S, et al.
出版: (2001)

Post-marketing drug withdrawals: pharmacovigilance success, regulatory problems : Arrêts de commercialisation de médicaments post-autorisation : succès de la pharmacovigilance, problèmes réglementaires
由: Aronson, J
出版: (2017)

Patient Reporting of Adverse Drug Reactions (ADRs)
由: Hariraj, Vidhya, et al.
出版: (2018)

Clinical pharmacology. Adverse drug interactions.
由: Aronson, J, et al.
出版: (1981)

The toxicological significance of post-mortem drug concentrations in bile
由: Ferner, RE, et al.
出版: (2017)

Adverse drug reactions (ADRs) in geriatric hospitalized patients=Adverse drug reaction (ADRs) pada pasien rawat inap geriatri
由: Perpustakaan UGM, i-lib
出版: (2008)

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
由: Rizzoli, R, et al.
出版: (2011)

A Pharmacoinformatic Prediction Model For Adverse Drug Reactions
由: Omar, Moayyad Jamal Abdel Jabbar Al
出版: (2010)

Drug-related postural hypotension: to withdraw or not to withdraw (a case series)
由: Mohamad, Fadzilah, et al.
出版: (2019)

Adverse drug reaction-related hospitalizations of adults in the Lao People's Democratic Republic: health risks of unknown medicines
由: Caillet, C, et al.
出版: (2016)